Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;45(1):54-57.
doi: 10.1002/cbin.11469. Epub 2020 Oct 10.

The possible double-edged sword effects of vitamin D on COVID-19: A hypothesis

Affiliations
Review

The possible double-edged sword effects of vitamin D on COVID-19: A hypothesis

Ehsan Shojaeefar et al. Cell Biol Int. 2021 Jan.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) gains access to host cells by attaching to angiotensin-converting enzyme 2 (ACE2). Vitamin D (VitD) can upregulate ACE2 and has an antagonistic effect on Renin, which exerts a vasodilatation and anti-inflammatory effect against coronavirus disease (COVID-19). However, it may also facilitate viral entry by increasing ACE2 as the main SARS-CoV-2 receptor and mediates ROS production through NADPH oxidase, as a double-edged sword effect. Lung function and the immune system are also influenced by VitD through several mechanisms, including increased natural antibiotics (Defensin and Cathelicidin) and upregulated transforming growth factor-β. A higher IgA, Th2/Th1 ratio, and T-regulatory cells are attributable to VitD effects on the immune cells, while these changes may also be a double-edged sword in COVID-19. Although VitD supplementation might be highly recommended in COVID-19, the administration's dosage and route could be challenging. Furthermore, this issue has not been mentioned in various studies so far. So, the report aimed to explain the current challenges with the application of VitD in COVID-19.

Keywords: COVID-19; angiotensin-converting enzyme 2; receptor; severe acute respiratory syndrome; supplementation; vitamin D.

PubMed Disclaimer

References

REFERENCES

    1. Andersen, L. B., Przybyl, L., Haase, N., von Versen-Höynck, F., Qadri, F., Jørgensen, J. S., Sorensen, G. L., Fruekilde, P., Poglitsch, M., Szijarto, I., Gollasch, M., Peters, J., Muller, D. N., Christesen, H. T., & Dechend, R. (2015). Vitamin D depletion aggravates hypertension and target-organ damage. Journal of the American Heart Association, 4(2), e001417. https://doi.org/10.1161/JAHA.114.001417
    1. Cazac, B. B., & Roes, J. (2000). TGF-β receptor controls B cell responsiveness and induction of IgA in vivo. Immunity, 13(4), 443-451. https://doi.org/10.1016/S1074-7613(00)00044-3
    1. Chen, Y., Guo, Y., Pan, Y., & Zhao, Z. J. (2020). Structure analysis of the receptor binding of 2019-nCoV. Biochemical and Biophysical Research Communications, 525(1), 135-140. https://doi.org/10.1016/j.bbrc.2020.02.071
    1. Di Rosa, M., Malaguarnera, M., Nicoletti, F., & Malaguarnera, L. (2011). Vitamin D3: A helpful immuno-modulator. Immunology, 134(2), 123-139. https://doi.org/10.1111/j.1365-2567.2011.03482.x
    1. Gilbert, C. R., Arum, S. M., & Smith, C. M. (2009). Vitamin D deficiency and chronic lung disease. Canadian Respiratory Journal, 16(3), 75-80. https://doi.org/10.1155/2009/829130

LinkOut - more resources